[ad_1] -Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial. HONG KONG, […]
Trending Stories
THE HONEST FARMER Co. Ltd Prepares Entry Into Vietnam’s Online Market With Healthy K-Snack Offering
[ad_1] SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ — Korean grain snack producer THE HONEST FARMER Co. Ltd announced plans to expand its presence in Vietnam’s fast-growing e-commerce sector with the launch of its Black […]
BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan
[ad_1] XI’AN, China, Dec. 10, 2025 /PRNewswire/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of […]
MARSTEK presentará los nuevos sistemas de almacenamiento de energía VENUS en el Foro EnerGaïa 2025
[ad_1] MONTPELLIER, Francia, 10 de diciembre de 2025 /PRNewswire/ — MARSTEK, líder global en innovación dentro del sector del almacenamiento energético, presentará sus más recientes avances de nueva generación en almacenamiento de energía y carga inteligente con los […]
3GWh! Risen Energy Secures New Global Energy Storage Deal!
[ad_1] NINGBO, China, Dec. 10, 2025 /PRNewswire/ — Recently, Risen Energy announced the signing of a 3 GWh energy storage system cooperation MOU with WEG, a leading Brazilian industrial giant. Pursuant to the MOU, Risen Energy […]
